CEA MANUSCRIPT CATEGORIES AND SUBMISSION REQUIREMENTS
Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Should not exceed 5,000 words and 8 illustrations. Suitable manuscripts include those dealing with: epidemiology, underlying mechanisms, diagnosis, treatment and prevention of allergic (and related) diseases. These might include the study of methods of controlling allergic reactions, human and animal models of hypersensitivity and other aspects of mechanistic and applied clinical allergy in its broadest sense including clinical trials. Specific study guidelines are included in the Main Text File section.
Review Articles – Solicited and unsolicited review articles and Opinion pieces on subjects of topical interest to experimental and clinical allergists. Systematic reviews are particularly encouraged. A review article is not the same as a systematic review. Most systematic reviews include meta-analysis, and those which don’t include meta-analysis should clearly explain why data extracted from the included studies were not suitable for meta-analysis.
Papers of a primarily methodological nature are not accepted.
Editorials – Are by invitation only.
Research Letters – Are considered. They should start “To the Editor”, have no abstract and be unstructured, be less than 1500 words in length, have less than 10 references, and a maximum of 2 figures or tables.
Correspondence – Correspondence concerning recent publications in the journal is occasionally published, dependent on space and priority rating. Letters that confirm previously published material without adding significant new information are less likely to be published. Correspondence letters must be submitted electronically to the Editorial Office ([email protected]), and should not be submitted online. The authors of the original work will be invited to respond.
The Journal does not publish case reports; authors of case reports are encouraged to submit to Wiley’s open access journal Immunity, Inflammation and Disease.
BSACI position statement: Cost of living, health inequalities – and the adverse additional impact on children and young people living with allergic conditions